The human Prion diseases can be classified into sporadic, acquired and inherited forms. Inherited forms usually manifest in higher age so there have to be factors preventing Prion propagation in young mutation carriers. Antibodies against the flexible tail of Prions have been shown to be protective in mice. The investigators intend to screen mutation carriers and controls for the presence of Prion autoantibodies.
Study Type
OBSERVATIONAL
Enrollment
213
UCSF Memory and Aging Center
San Francisco, California, United States
Medical University Graz
Graz, Austria
University Medical Center Göttingen
Göttingen, Germany
CJD Foundation Israel
Pardés H̱anna Karkur, Israel
Anti-Prion protein autoantibody levels
Time frame: Baseline, up to 90 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Istituto di Ricerche Farmacologiche
Milan, Italy
Slovak Medical University
Bratislava, Slovakia
Institute of Neuropathology
Zurich, Switzerland